# Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.

> **NCT04747002** · PHASE2 · UNKNOWN · sponsor: **Osaka University** · enrollment: 100 (estimated)

## Conditions studied

- Acute Myeloid Leukemia in Remission

## Interventions

- **DRUG:** DSP-7888

## Key facts

- **NCT ID:** NCT04747002
- **Lead sponsor:** Osaka University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-12
- **Primary completion:** 2024-03
- **Final completion:** 2024-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04747002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04747002, "Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04747002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*